あすか製薬ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/07/09 | 2,454 | 2,454 | 2,404 | 2,404 | -65 | -2.6% | 44,200 |
2025/07/08 | 2,466 | 2,480 | 2,451 | 2,469 | +17 | +0.7% | 36,000 |
2025/07/07 | 2,459 | 2,470 | 2,441 | 2,452 | -7 | -0.3% | 27,700 |
2025/07/04 | 2,464 | 2,472 | 2,451 | 2,459 | -6 | -0.2% | 17,200 |
2025/07/03 | 2,478 | 2,494 | 2,456 | 2,465 | +8 | +0.3% | 51,000 |
2025/07/02 | 2,440 | 2,458 | 2,407 | 2,457 | -17 | -0.7% | 52,300 |
2025/07/01 | 2,469 | 2,479 | 2,439 | 2,474 | +27 | +1.1% | 41,700 |
2025/06/30 | 2,447 | 2,459 | 2,423 | 2,447 | +18 | +0.7% | 31,100 |
2025/06/27 | 2,450 | 2,469 | 2,400 | 2,429 | -13 | -0.5% | 59,500 |
2025/06/26 | 2,424 | 2,451 | 2,414 | 2,442 | +40 | +1.7% | 43,600 |
2025/06/25 | 2,348 | 2,418 | 2,342 | 2,402 | +4 | +0.2% | 46,400 |
2025/06/24 | 2,475 | 2,478 | 2,393 | 2,398 | -74 | -3% | 26,500 |
2025/06/23 | 2,402 | 2,488 | 2,392 | 2,472 | +66 | +2.7% | 58,100 |
2025/06/20 | 2,365 | 2,406 | 2,352 | 2,406 | +50 | +2.1% | 82,300 |
2025/06/19 | 2,360 | 2,362 | 2,331 | 2,356 | -7 | -0.3% | 27,300 |
2025/06/18 | 2,358 | 2,366 | 2,345 | 2,363 | +34 | +1.5% | 21,800 |
2025/06/17 | 2,318 | 2,333 | 2,299 | 2,329 | -1 | ±0% | 25,500 |
2025/06/16 | 2,367 | 2,367 | 2,324 | 2,330 | -5 | -0.2% | 25,100 |
2025/06/13 | 2,349 | 2,358 | 2,329 | 2,335 | +6 | +0.3% | 44,400 |
2025/06/12 | 2,341 | 2,354 | 2,313 | 2,329 | -13 | -0.6% | 28,700 |
2025/06/11 | 2,316 | 2,350 | 2,301 | 2,342 | +40 | +1.7% | 28,900 |
2025/06/10 | 2,312 | 2,322 | 2,298 | 2,302 | -10 | -0.4% | 33,000 |
2025/06/09 | 2,302 | 2,315 | 2,300 | 2,312 | +1 | ±0% | 17,600 |
2025/06/06 | 2,321 | 2,325 | 2,300 | 2,311 | +11 | +0.5% | 20,300 |
2025/06/05 | 2,300 | 2,313 | 2,282 | 2,300 | -22 | -0.9% | 36,200 |
2025/06/04 | 2,310 | 2,345 | 2,310 | 2,322 | +24 | +1% | 38,000 |
2025/06/03 | 2,302 | 2,329 | 2,286 | 2,298 | -13 | -0.6% | 41,500 |
2025/06/02 | 2,326 | 2,343 | 2,301 | 2,311 | -24 | -1% | 29,300 |
2025/05/30 | 2,301 | 2,349 | 2,301 | 2,335 | +21 | +0.9% | 26,500 |
2025/05/29 | 2,334 | 2,351 | 2,313 | 2,314 | +5 | +0.2% | 38,100 |
2025/05/28 | 2,323 | 2,325 | 2,295 | 2,309 | -2 | -0.1% | 25,900 |
2025/05/27 | 2,300 | 2,321 | 2,288 | 2,311 | -10 | -0.4% | 24,700 |
2025/05/26 | 2,336 | 2,356 | 2,311 | 2,321 | -29 | -1.2% | 20,100 |
2025/05/23 | 2,367 | 2,370 | 2,340 | 2,350 | +7 | +0.3% | 16,000 |
2025/05/22 | 2,304 | 2,365 | 2,303 | 2,343 | +12 | +0.5% | 29,400 |
2025/05/21 | 2,335 | 2,367 | 2,327 | 2,331 | -4 | -0.2% | 27,500 |
2025/05/20 | 2,350 | 2,377 | 2,301 | 2,335 | -16 | -0.7% | 49,200 |
2025/05/19 | 2,373 | 2,374 | 2,330 | 2,351 | -22 | -0.9% | 53,200 |
2025/05/16 | 2,544 | 2,544 | 2,373 | 2,373 | +79 | +3.4% | 91,300 |
2025/05/15 | 2,260 | 2,297 | 2,260 | 2,294 | +39 | +1.7% | 45,200 |
2025/05/14 | 2,254 | 2,283 | 2,228 | 2,255 | +1 | ±0% | 35,800 |
2025/05/13 | 2,216 | 2,300 | 2,170 | 2,254 | -62 | -2.7% | 65,900 |
2025/05/12 | 2,317 | 2,329 | 2,298 | 2,316 | -10 | -0.4% | 40,400 |
2025/05/09 | 2,317 | 2,401 | 2,234 | 2,326 | +9 | +0.4% | 110,800 |
2025/05/08 | 2,327 | 2,353 | 2,289 | 2,317 | +11 | +0.5% | 52,400 |
2025/05/07 | 2,261 | 2,359 | 2,261 | 2,306 | +10 | +0.4% | 94,400 |
2025/05/02 | 2,300 | 2,314 | 2,287 | 2,296 | -4 | -0.2% | 34,800 |
2025/05/01 | 2,324 | 2,324 | 2,299 | 2,300 | -24 | -1% | 21,600 |
2025/04/30 | 2,334 | 2,345 | 2,303 | 2,324 | +7 | +0.3% | 35,900 |
2025/04/28 | 2,330 | 2,330 | 2,293 | 2,317 | +17 | +0.7% | 134,000 |
1~
50
件表示中 / 1046件
類似銘柄と比較する
現在ご覧いただいている「あすかHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
あすかHD | 240,400円 | +16.9% | +33.2% | 2.29% | 13.11倍 | 1.04倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
ネクセラファーマ | 85,300円 | +20.3% | - | 0.00% | 151.24倍 | 1.13倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
ハートシード | 312,500円 | +174.2% | - | 0.00% | - | 9.38倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
タウンズ | 53,000円 | +4.6% | +6.1% | 5.28% | 9.04倍 | 3.34倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
ヘリオス | 50,700円 | +150.0% | - | 0.00% | - | 25.72倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム